Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs: Interactions between herbal extracts and drugs K. Fukunaga & K. Orito Time-course effects of St John's wort

Journal of Veterinary Pharmacology and Therapeutics

Volumn 35, Issue 5, 2012, Pages 446-451

  Fukunaga, K ^a   Orito, K ^a  

^a AZABU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; HYPERICUM PERFORATUM EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; EXPERIMENTAL DOG; HERB DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; ULTRAVIOLET SPECTROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS; AREA UNDER CURVE; CYCLOSPORINE; DOGS; HERB-DRUG INTERACTIONS; HYPERICUM; IMMUNOSUPPRESSIVE AGENTS; MALE;

CANIS FAMILIARIS;

EID: 84866182232     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2011.01348.x     Document Type: Article

References (30)

1. Bauer, S., Störmer, E., Johne, A., Kruger, H., Budde, K., Neumayer, H.H., Roots, I. & Mai, I. (2003) Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. British Journal of Clinical Pharmacology, 55, 203-211.
2. Bray, B.J., Brennan, N.J., Perry, N.B., Menkes, D.B. & Rosengren, R.J. (2002a) Short term treatment with St John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse. Life Sciences, 70, 1325-1335.
3. Bray, B.J., Perry, N.B., Menkes, D.B. & Rosengren, R.J. (2002b) St John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. Toxicological Sciences, 66, 27-33.
4. Butterweck, V. & Schmidt, M. (2007) St John's wort: role of active compounds for its mechanism of action and efficacy. Wiener Medizinische Wochenschrift, 157, 356-361.
5. Christians, U., Strohmeyer, S., Kownatzki, R., Schiebel, H.M., Bleck, J., Kohlhaw, K., Schottmann, R. & Sewing, K.F. (1991) Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomes. Xenobiotica, 21, 1199-1210.
6. Dresser, G.K., Schwarz, U.I., Wilkinson, G.R. & Kim, R.B. (2003) Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clinical Pharmacology and Therapeutics, 73, 41-50.
7. Dürr, D., Stieger, B., Kullak-Ublick, G.A., Rentsch, K.M., Steinert, H.C., Meier, P.J. & Fattinger, K. (2000) St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clinical Pharmacology and Therapeutics, 68, 598-604.
8. Garg, V., van Heeswijk, R., Lee, J.E., Alves, K., Nadkarni, P. & Luo, X. (2011) Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus. Hepatology, 54, 20-27.
9. Group., H.D.T.S. (2002) Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA, 287, 1807-1814.
10. Hall, S.D., Wang, Z., Huang, S.M., Hamman, M.A., Vasavada, N., Adigun, A.Q., Hilligoss, J.K., Miller, M. & Gorski, J.C. (2003) The interaction between St John's wort and an oral contraceptive. Clinical Pharmacology and Therapeutics, 74, 525-535.
11. Johne, A., Bröckmoller, J., Bauer, S., Maurer, A., Langheinrich, M. & Roots, I. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clinical Pharmacology and Therapeutics, 66, 338-345.
12. Kageyama, M., Fukushima, K., Togawa, T., Fujimoto, K., Taki, M., Nishimura, A., Ito, Y., Sugioka, N., Shibata, N. & Takada, K. (2006) Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers. Biological and Pharmaceutical Bulletin, 29, 779-784.
13. Katayama, M., Igarashi, H., Tani, K., Nezu, Y., Harada, Y., Yogo, T., Hara, Y., Aoki, S. & Tagawa, M. (2008) Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. Journal of Veterinary Medical Science, 70, 85-88.
14. Kelly, P.A., Wang, H., Napoli, K.L., Kahan, B.D. & Strobel, H.W. (1999) Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4. European Journal of Drug Metabolism and Pharmacokinetics, 24, 321-328.
15. King, J.N., Simpson, B.S., Overall, K.L., Appleby, D., Pageat, P., Ross, C., Chaurand, J.P., Heath, S., Beata, C., Weiss, A.B., Muller, G., Paris, T., Bataille, B.G., Parker, J., Petit, S. & Wren, J. (2000) Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial. Applied Animal Behaviour Science, 67, 255-275.
16. Lensmeyer, G.L., Wiebe, D.A. & Carlson, I.H. (1989) Distribution of cyclosporin A metabolites among plasma and cells in whole blood: effect of temperature, hematocrit, and metabolite concentration. Clinical Chemistry, 35, 56-63.
17. Mai, I., Bauer, S., Perloff, E.S., Johne, A., Uehleke, B., Frank, B., Budde, K. & Roots, I. (2004) Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction. Clinical Pharmacology and Therapeutics, 76, 330-340.
18. Mannel, M., Kuhn, U., Schmidt, U., Ploch, M. & Murck, H. (2010) St John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial. Journal of Psychiatric Research, 44, 760-767.
19. Markowitz, J.S., Donovan, J.L., DeVane, C.L., Taylor, R.M., Ruan, Y., Wang, J.S. & Chavin, K.D. (2003) Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA, 290, 1500-1504.
20. Moore, L.B., Goodwin, B., Jones, S.A., Wisely, G.B., Serabjit-Singh, C.J., Willson, T.M., Collins, J.L. & Kliewer, S.A. (2000) St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proceedings of the National Academy of Sciences of the United States of America, 97, 7500-7502.
21. Neary, J.T. & Bu, Y. (1999) Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Research, 816, 358-363.
22. Niwa, T., Yamamoto, S., Saito, M., Shiraga, T. & Takagi, A. (2007) Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. Yakugaku Zasshi, 127, 209-216.
23. Patricelli, A.J., Hardie, R.J. & McAnulty, J.E. (2002) Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. Journal of the American Veterinary Medical Association, 220, 1009-1016.
24. Radwanski, N.E., Cerundolo, R., Shofer, F.S., Hanley, M.J. & Court, M.H. (2011) Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs. American Journal of Veterinary Research, 72, 687-693.
25. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A. & Borst, P. (1995) Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal of Clinical Investigation, 96, 1698-1705.
26. Shah, A.K. & Sawchuk, R.J. (1988) Improved liquid-chromatographic determination of cyclosporine and its metabolites in blood. Clinical Chemistry, 34, 1467-1471.
27. Shelton, R.C. (2009) St John's wort (Hypericum perforatum) in major depression. Journal of Clinical Psychiatry, 70 (Suppl. 5), 23-27.
28. Steffan, J., Strehlau, G., Maurer, M. & Rohlfs, A. (2004) Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs. Journal of Veterinary Pharmacology and Therapeutics, 27, 231-238.
29. Wang, L.S., Zhou, G., Zhu, B., Wu, J., Wang, J.G., Abd El-Aty, A.M., Li, T., Liu, J., Yang, T.L., Wang, D., Zhong, X.Y. & Zhou, H.H. (2004) St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clinical Pharmacology and Therapeutics, 75, 191-197.
30. Xu, H., Williams, K.M., Liauw, W.S., Murray, M., Day, R.O. & McLachlan, A.J. (2008) Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. British Journal of Pharmacology, 153, 1579-1586.